IMNM
Immunome Inc
21.40$
-4.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.3% | -73.1% | +129.7% | +23.1% | -5.9% | +6.9% | +37.2% | -100.0% | – | – | – | – | |
| – | +54.8% | +2.3% | +155.9% | -15.2% | +4.2% | +22.0% | -0.8% | +6,732.4% | -98.4% | -3.0% | – | – | |
| – | +12.6% | -73.1% | +129.7% | +23.1% | -5.9% | +6.9% | +12.6% | -1,593.0% | – | – | – | – | |
| – | +152.1% | +59.5% | +89.2% | +27.9% | +28.7% | -23.0% | +9.7% | +21.6% | +23.5% | -23.7% | +29.1% | – | |
| – | +83.8% | -25.3% | +16.2% | +36.5% | +9.7% | +2.3% | -6.1% | +9.0% | +10.5% | +7.1% | +40.9% | – | |
| – | +1,126.1% | +35.4% | -68.2% | +26.1% | +60.4% | -44.5% | +4.6% | -78.0% | +565.7% | -19.6% | +33.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.